Cantor Fitzgerald Sticks to Its Buy Rating for Anteris Technologies Global Corp. (AVR)
at www.tipranks.com (Fri, 27-Mar 7:25 AM)
Medtronic’s $90 Million Investment Propels Anteris’ TAVR Ambitions—What’s Next for the DurAVR Valve?
Market Chameleon (Fri, 23-Jan 8:31 AM)
Medtronic’s Strategic Stake Signals Confidence in Anteris’ $200M Offering—What Does It Mean for AVR?
Market Chameleon (Wed, 21-Jan 9:55 AM)
Market Chameleon (Wed, 21-Jan 7:06 AM)